跳到正文
原文
Endpoints News 生物医药· Max Bayer·· 2026-10-01AI 评分20

立法者就致幻剂资格认证意见不一

Lawmakers hear mixed opinions on psychedelics credentialing

AI 导读

随着致幻剂药物逐渐接近商业化,两名众议院立法者正在为其推广及潜在伴随立法规划路径。立法者们在致幻剂资格认证问题上持有不同意见。

正文

As psy­che­del­ic drugs inch clos­er to com­mer­cial­iza­tion, two House law­mak­ers are chart­ing a path for­ward for their in­evitable roll­out and what any po­ten­tial ac­com­pa­ny­ing leg­is­la­tion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news